John Mix, MD
Vascular Surgery · Macon, GANPI 1558543389
Payments from drug & device makers
Across 339 payments — averaging $51.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$4K
- W. L. Gore & Associates, Inc.$3K
- Boston Scientific$3K
- Penumbra, Inc.$3K
- Medtronic$2K
- Bard Peripheral Vascular, Inc.$339
- plus $2K from 35 others
Across 1 payment — averaging $3500.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$4K
What the payments were for
- Travel & lodging$3,45521%
- Food & beverage$13,23279%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 20 | $4,184 |
| W. L. Gore & Associates, Inc. | 99 | $3,097 |
| Boston Scientific | 58 | $2,950 |
| Penumbra, Inc. | 15 | $2,591 |
| Medtronic(3 entities) | 47 | $1,965 |
| Bard Peripheral Vascular, Inc. | 14 | $339 |
| Angiodynamics, Inc. | 4 | $278 |
| Philips North America LLC | 12 | $204 |
| Stryker | 3 | $182 |
| Johnson & Johnson | 11 | $174 |
| Abbott | 6 | $130 |
| Polynovo North America LLC | 2 | $127 |
| Lemaitre Vascular, Inc. | 2 | $124 |
| Cook Medical LLC | 1 | $112 |
| Cvrx, Inc. | 3 | $69 |
| Shockwave Medical, Inc | 4 | $64 |
| Artivion, Inc. | 2 | $61 |
| Silk Road Medical, Inc. | 3 | $57 |
| Imperative Care, Inc | 2 | $48 |
| Baxter Healthcare | 2 | $48 |
| Terumo Medical Corporation | 3 | $47 |
| GE HealthCare | 1 | $47 |
| Organogenesis Inc. | 2 | $45 |
| Davol Inc. | 1 | $45 |
| Argon Medical Devices, Inc. | 2 | $39 |
| Inari Medical, Inc. | 1 | $39 |
| Pfizer | 3 | $38 |
| Kerecis Limited | 2 | $38 |
| Solventum Corporation | 2 | $36 |
| Convatec Inc. | 1 | $33 |
| Biom'up France SAS | 1 | $29 |
| Humacyte Global, Inc. | 1 | $29 |
| Mimedx Group, Inc. | 1 | $23 |
| Neuros Medical, Inc. | 1 | $20 |
| Cardiovascular Systems Inc. | 1 | $20 |
| Cardinal Health 200 LLC | 1 | $18 |
| Aroa Biosurgery Incorporated | 1 | $16 |
| EKOS Corporation | 1 | $14 |
| Acell, Inc. | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Sirtex Medical Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,149
- AFX$1,922
- Ovation$1,795
- GORE TAG Thoracic Endoprosthesis$1,144
- Alto Abdominal Stent Graft System$793
- GENERAL VASCULAR INTERVENTION$749
- AFX2 Bifurcated Endograft System$562
- Varithena Administration Pack$432
- ENDOCROSS Device$262
- Torus Stent Graft System$262
- Abre$238
- Penumbra System$163
- Ranger$131
- Cook Medical AAA$112
How this compares
$17,409 in reported general payments places this provider in the 70th percentile of 176 vascular surgery providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 20 | $15,765 |
| XareltoRivaroxaban | 17 | $12,871 |
| Cilostazol | 85 | $1,885 |
| ClopidogrelClopidogrel Bisulfate | 144 | $1,188 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $297 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $91 |
| Methylprednisolone | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $38 | $15,76520 claims |
| Johnson & JohnsonXarelto | $174 | $12,87117 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 176 vascular surgery providers in Georgia.
Other vascular surgery in Macon
- Michael KlyachkinMacon$63K
- Magendran DanapalMacon$31K
- Suman AnnambhotlaGainesville$986K
- Siddharth PatelAtlanta$381K
- Yazan DuwayriAtlanta$284K
- Houman TamaddonAugusta$242K
- William JordanAugusta$211K
- Charles RossAtlanta$178K
- Juan AyerdiColumbus$130K
- Steven OweidaMarietta$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.